|
|
|
|
| LEADER |
01081cam a2200289 a 4500 |
| 001 |
INLIS000000000315621 |
| 005 |
20111004131042.42 |
| 006 |
a####g#####i00000# |
| 007 |
ta |
| 008 |
111004s1969####sz#####g#####i00000#eng## |
| 035 |
# |
# |
|a 0010-50846360
|
| 040 |
# |
# |
|a jkpnpna
|b eng
|
| 041 |
0 |
# |
|a eng
|
| 082 |
1 |
4 |
|a 616.99
|2 [22]
|
| 090 |
# |
# |
|a U.N.:-110 no.422-436. 1969
|
| 245 |
0 |
0 |
|a Principles for the testing and evaluation of drugs for carcinogenity /
|c report of a WHO Scientific Group
|
| 260 |
# |
# |
|a Geneva :
|b World Health Organization,
|c 1969
|
| 300 |
# |
# |
|a 26 hlm. ;
|c 24 cm.
|
| 440 |
# |
0 |
|a World Health Organization Technical Report Series;
|v 426
|
| 500 |
# |
# |
|a Dijilid dalam satu buku : World Health Organization Technical Report Series (no. 422 - no. 436)
|
| 650 |
# |
4 |
|a Bahan obat
|x Pengujian
|
| 650 |
# |
4 |
|a Kanker
|x Diagnosis
|
| 740 |
0 |
# |
|a World Health Organization Technical Report Series (no. 422 - no. 436)
|
| 850 |
# |
# |
|a JKPNPNA
|
| 900 |
# |
# |
|a 00851nbm**2200012*a*4500
|
| 902 |
# |
# |
|a INDOLI20:04-OCT-11*INDOLI20:04-OCT-11*131918104:25-APR-13*131918104:25-APR-13*
|
| 999 |
# |
# |
|a 1519/1969
|
